1. Lian, Zengzhi, Pang, Pei, Zhu, Yan, Du, Wenwen, Zhou, Jintao. 2022. Prognostic Value and Potential Mechanism of MTFR2 in Lung Adenocarcinoma. In Frontiers in oncology, 12, 832517. doi:10.3389/fonc.2022.832517. https://pubmed.ncbi.nlm.nih.gov/35600359/
2. Lu, Guanming, Lai, Yuanhui, Wang, Tiantian, Liu, Ruilei, Li, Jie. 2019. Mitochondrial fission regulator 2 (MTFR2) promotes growth, migration, invasion and tumour progression in breast cancer cells. In Aging, 11, 10203-10219. doi:10.18632/aging.102442. https://pubmed.ncbi.nlm.nih.gov/31740625/
3. Wang, Wei, Xiong, Meihua, Jiang, Lin, Chen, Zean, Shao, Yisen. 2020. MTFR2 Promotes the Proliferation, Migration, and Invasion of Oral Squamous Carcinoma by Switching OXPHOS to Glycolysis. In Frontiers in oncology, 10, 858. doi:10.3389/fonc.2020.00858. https://pubmed.ncbi.nlm.nih.gov/32537437/
4. Li, Dan, Ji, YanMei, Guo, JiaLong, Guo, Qiang. 2021. Upregulated expression of MTFR2 as a novel biomarker predicts poor prognosis in hepatocellular carcinoma by bioinformatics analysis. In Future oncology (London, England), 17, 3187-3201. doi:10.2217/fon-2020-1160. https://pubmed.ncbi.nlm.nih.gov/34156259/
5. Chen, Cheng, Tang, Yang, Qu, Wen-Dong, Song, Yong-Xiang, Ke, Xi-Xian. 2021. Evaluation of clinical value and potential mechanism of MTFR2 in lung adenocarcinoma via bioinformatics. In BMC cancer, 21, 619. doi:10.1186/s12885-021-08378-3. https://pubmed.ncbi.nlm.nih.gov/34039308/
6. Zhu, Hai, Wang, Gang, Zhu, Haixing, Xu, Aman. 2021. MTFR2, A Potential Biomarker for Prognosis and Immune Infiltrates, Promotes Progression of Gastric Cancer Based on Bioinformatics Analysis and Experiments. In Journal of Cancer, 12, 3611-3625. doi:10.7150/jca.58158. https://pubmed.ncbi.nlm.nih.gov/33995638/
智鼠故事 
